//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Look, people. We have superb keynotes, we are giving prizes, we are giving postdocs a megaphone to tell everyone why they should be hired. This is the meeting to be at. Sign up, join us, and have the time of your life while discussing science with people that know where the cleithrum is🐟🧪
I don't understand the "being left behind" genAI argument tbh. We all have been trained very specifically to read, write and think. We all knew how to do those things three years ago. If they didn't exist, we'd still be doing science. When the bubble pops, we will still do science🧪
19h
CDK4/6 Endothelial Cell Cycle #ArterioVenousMalformation #HereditaryHemorrhagicTelangiectasia Evidence from 👉Fucci2🐭 (fluorescent cell cycle reporter) Retina +BMP9/10 blocking Ab +Palbociclib CDK4/6i 👉🐭EC ALK1 KO👁️🧠 +Palbociclib 👉👤HHT2 Skin biopsy #CircAHA 2024 www.ahajournals.org/doi/full/10....
Well, you posted it, so I had expected that you had critically read it first. Assuming what the antibodies might be just creates more confusion. As for MDPI, the journals do vary in quality. However, perhaps you'd like to send something to Proteomes & we'll see how it stands up to critical review.
Our latest IRAD paper, somewhat counterintuitive results but the facts are facts, I'd love to hear what everyone thinks authors.elsevier.com/c/1nFQe2ecZf...
www.cell.com/trends/immun...